In ovarian cancer, OPG not only attenuated TRAIL-induced apoptosis via a TRAIL-binding manner, but also stimulated the activation of pro-survival Protein kinase B (Akt) signaling via integrin/FAK signaling and inhibited TRAIL-induced apoptosis[50]. The gene discussed is TNFRSF11B; the disease is ovarian carcinoma.